Aleafia Health Inc. (OTCQX: ALEAF) is a leading, vertically integrated cannabis company with major cannabis cultivation & processing and medical c...
CannaRoyalty, Increasing Revenues as the Cannabis Sector Gains Traction, Analyst Research
CannaRoyalty Corp. (OTCQX: CNNRF) is a North American cannabis consumer product company currently focused on building a leading distribution business ...
Freedom Leaf is Growing Through Acquisition and Investment
Freedom Leaf Inc. (OTCQB: FRLF) is a group of diversified, international, vertically-integrated hemp businesses concentrating on health, wellness, and...
KushCo Holdings, Cannabis Company Revenue Up by Triple Digits, Analysts Review and Target
KushCo Holdings, Inc. (OTCQB: KSHB) is the parent company to a diverse group of business units that are transformative leaders in the cannabis, CBD an...
Auxly Cannabis Business Model, Verticals and Operational Highlights
Auxly Cannabis Group Inc. (OTCQX – CBWTF) is creating a world-class platform by forming partnerships with best-in-class cultivators, product inn...
Youngevity International Entry into the Hemp Based Non-THC CBD Business
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model, that ...
Titan Pharmaceuticals Moving Forward with its ProNeura™ Technology, Analysts Review
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), based in South San Francisco, CA, is a commercial stage company developing proprietary therapeutics with i...
vTv Therapeutics Shares Soar in October, Near Term Catalysts, Analysts review and Target
vTv Therapeutics Inc. (NASDAQ: VTVT) is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered sma...
Trovagene Advances its Clinical Development of PCM-075, Analysts review and Target
Trovagene, Inc. (NASDAQ: TROV) is a clinical-stage, oncology therapeutics company, using a precision medicine approach to develop drugs that target mi...
Novavax Shares Gain as its Lead Compounds Move Forward, Analysts Review and Target
Novavax (NASDAQ: NVAX) is up a mind blowing 6300% following our coverage in 2018 here!